Define IP Performance Indicators and Escalation Risk Triggers
Establish quantitative and qualitative criteria to judge the strength and commercial utility of the IP portfolio, such as claim breadth and freedom-to-operate clearance. Set explicit risk triggers—such as examiner rejections, competing patent publications, or valuation disputes—that mandate immediate strategic reviews.
Completing this action establishes objective benchmarks for IP success and clear thresholds for corrective action. It prevents continuous expenditure on weak or unindemnified patent claims that offer minimal commercial defensibility.
The founder must output a defined IP Scorecard and Risk Trigger Framework containing measurable thresholds for filing decisions, budget ceilings, and strategic pivot triggers. Every trigger must be mapped to a predefined mitigation protocol.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What specific patent examiner response or claim narrowing would trigger an immediate re-evaluation of your venture valuation?
- 2
How do your success criteria differentiate between mere patent allowance and true commercial defensibility in your core markets?
- 3
What financial or legal threshold automatically escalates an IP dispute with the university to board-level arbitration?
- 4
Why is your chosen threshold for Freedom-to-Operate risk sufficient to satisfy tier-one venture capital due diligence?
- 5
What risk triggers are in place to stop patent spending if market feedback shows customers prefer a non-patented alternative approach?